RS
LLY icon

Robeco Schweiz’s Eli Lilly LLY Stock Holding History

Robeco Schweiz’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Buy
1,627
+185
+13% +$189K 0.03% 117
2026
Q1 		$1.33M Buy
+1,442
New +$1.46M 0.03% 121
2022
Q4 		– Sell
-32,182
Closed -$10.4M – 142
2022
Q3 		$10.4M Buy
32,182
+24,139
+300% +$7.65M 0.2% 97
2022
Q2 		$2.61M Buy
+8,043
New +$2.41M 0.05% 131

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Robeco Schweiz's LLY Position: Q2 2026 in Review

Robeco Schweiz increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $189K and bringing the position to 1,627 shares worth $1.95M. The position accounts for 0.03% of the portfolio, ranked #117.

Robeco Schweiz first reported a position in LLY in Q2 2022 and has held it in 4 quarters since. The position peaked at $10.4M in Q3 2022. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Robeco Schweiz held 1,627 shares of Eli Lilly worth $1.95M as of Q2 2026.
  • Robeco Schweiz bought 185 Eli Lilly shares in Q2 2026, an estimated $189K.
  • Eli Lilly made up 0.03% of Robeco Schweiz's portfolio in Q2 2026, its #117 holding.
  • Robeco Schweiz first reported a position in Eli Lilly in Q2 2022 and has held it in 4 quarters since.
  • Robeco Schweiz's Eli Lilly position peaked at $10.4M in Q3 2022.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Robeco Schweiz's 13F filing for Q2 2026, filed 28 Jul 2026.